Establishment and characterization of a new human prostatic cancer cell line: DuCaP

Y. G. Lee, S. Korenchuk, J. Lehr, S. Whitney, R. Vessela, Kenneth Pienta

Research output: Contribution to journalArticle

Abstract

Background: The lack of appropriate, clinically relevant, cell-based model systems has limited prostate cancer research and the development of new therapeutic modalities. Here we report the isolation and characterization of a new adherent prostate cancer cell line, derived from the dura mater of a cancer patient. Methods: Prostate cancer tissue was harvested at autopsy from a metastatic lesion to the dura mater of a patient with hormone refractory prostate cancer. This tissue was xenografted into SCID mice and later harvested and plated on tissue culture dishes. For characterization, soft agar clonegenic assay, in vivo xenograft growth, in vitro doubling time, karyotype analysis, immunocytochemistry for cytokeratin-18, androgen receptor, and PAP (prostatic acid phosphatase) expression, RT PCR for PAP, PSMA (prostate specific membrane antigen), expression and northern and western blot analysis to determine expression of Rb and p53, were performed. Results: DuCap grows in vitro (passage 55), forms colonies in soft agar, produces tumors in SCID mice (xenograft passage 12), and is androgen sensitive. DNA content was hypertriploid. PSA was detected in mouse serum and media. Cells were AR, PAP and cytokeratin-18 positive by immunocytochemistry. PSMA and PAP were detected by RT-PCR. AR, P53, and Rb were expressed in Northern blot analysis. P53 protein was detected in Western blot analysis but Rb protein was not. Conclusions: This cell line exhibits many phenotypic characteristics of clinical prostate carcinoma, including expression of PSA, PSMA, PAP and AR.

Original languageEnglish (US)
Pages (from-to)157-162
Number of pages6
JournalIn vivo (Athens, Greece)
Volume15
Issue number2
StatePublished - 2001
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Cells
Cell Line
Keratin-18
Dura Mater
SCID Mice
Heterografts
Northern Blotting
Agar
Western Blotting
Immunohistochemistry
Tissue
Polymerase Chain Reaction
Retinoblastoma Protein
Tissue culture
Androgen Receptors
Karyotype
Refractory materials
Androgens
Tumors

Keywords

  • Cell line
  • Model
  • Prostate cancer
  • Prostate specific antigen
  • Xenograft

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lee, Y. G., Korenchuk, S., Lehr, J., Whitney, S., Vessela, R., & Pienta, K. (2001). Establishment and characterization of a new human prostatic cancer cell line: DuCaP. In vivo (Athens, Greece), 15(2), 157-162.

Establishment and characterization of a new human prostatic cancer cell line : DuCaP. / Lee, Y. G.; Korenchuk, S.; Lehr, J.; Whitney, S.; Vessela, R.; Pienta, Kenneth.

In: In vivo (Athens, Greece), Vol. 15, No. 2, 2001, p. 157-162.

Research output: Contribution to journalArticle

Lee, YG, Korenchuk, S, Lehr, J, Whitney, S, Vessela, R & Pienta, K 2001, 'Establishment and characterization of a new human prostatic cancer cell line: DuCaP', In vivo (Athens, Greece), vol. 15, no. 2, pp. 157-162.
Lee, Y. G. ; Korenchuk, S. ; Lehr, J. ; Whitney, S. ; Vessela, R. ; Pienta, Kenneth. / Establishment and characterization of a new human prostatic cancer cell line : DuCaP. In: In vivo (Athens, Greece). 2001 ; Vol. 15, No. 2. pp. 157-162.
@article{13dfc36f012043a0997933d3a6ce759f,
title = "Establishment and characterization of a new human prostatic cancer cell line: DuCaP",
abstract = "Background: The lack of appropriate, clinically relevant, cell-based model systems has limited prostate cancer research and the development of new therapeutic modalities. Here we report the isolation and characterization of a new adherent prostate cancer cell line, derived from the dura mater of a cancer patient. Methods: Prostate cancer tissue was harvested at autopsy from a metastatic lesion to the dura mater of a patient with hormone refractory prostate cancer. This tissue was xenografted into SCID mice and later harvested and plated on tissue culture dishes. For characterization, soft agar clonegenic assay, in vivo xenograft growth, in vitro doubling time, karyotype analysis, immunocytochemistry for cytokeratin-18, androgen receptor, and PAP (prostatic acid phosphatase) expression, RT PCR for PAP, PSMA (prostate specific membrane antigen), expression and northern and western blot analysis to determine expression of Rb and p53, were performed. Results: DuCap grows in vitro (passage 55), forms colonies in soft agar, produces tumors in SCID mice (xenograft passage 12), and is androgen sensitive. DNA content was hypertriploid. PSA was detected in mouse serum and media. Cells were AR, PAP and cytokeratin-18 positive by immunocytochemistry. PSMA and PAP were detected by RT-PCR. AR, P53, and Rb were expressed in Northern blot analysis. P53 protein was detected in Western blot analysis but Rb protein was not. Conclusions: This cell line exhibits many phenotypic characteristics of clinical prostate carcinoma, including expression of PSA, PSMA, PAP and AR.",
keywords = "Cell line, Model, Prostate cancer, Prostate specific antigen, Xenograft",
author = "Lee, {Y. G.} and S. Korenchuk and J. Lehr and S. Whitney and R. Vessela and Kenneth Pienta",
year = "2001",
language = "English (US)",
volume = "15",
pages = "157--162",
journal = "In Vivo",
issn = "0258-851X",
publisher = "International Institute of Anticancer Research",
number = "2",

}

TY - JOUR

T1 - Establishment and characterization of a new human prostatic cancer cell line

T2 - DuCaP

AU - Lee, Y. G.

AU - Korenchuk, S.

AU - Lehr, J.

AU - Whitney, S.

AU - Vessela, R.

AU - Pienta, Kenneth

PY - 2001

Y1 - 2001

N2 - Background: The lack of appropriate, clinically relevant, cell-based model systems has limited prostate cancer research and the development of new therapeutic modalities. Here we report the isolation and characterization of a new adherent prostate cancer cell line, derived from the dura mater of a cancer patient. Methods: Prostate cancer tissue was harvested at autopsy from a metastatic lesion to the dura mater of a patient with hormone refractory prostate cancer. This tissue was xenografted into SCID mice and later harvested and plated on tissue culture dishes. For characterization, soft agar clonegenic assay, in vivo xenograft growth, in vitro doubling time, karyotype analysis, immunocytochemistry for cytokeratin-18, androgen receptor, and PAP (prostatic acid phosphatase) expression, RT PCR for PAP, PSMA (prostate specific membrane antigen), expression and northern and western blot analysis to determine expression of Rb and p53, were performed. Results: DuCap grows in vitro (passage 55), forms colonies in soft agar, produces tumors in SCID mice (xenograft passage 12), and is androgen sensitive. DNA content was hypertriploid. PSA was detected in mouse serum and media. Cells were AR, PAP and cytokeratin-18 positive by immunocytochemistry. PSMA and PAP were detected by RT-PCR. AR, P53, and Rb were expressed in Northern blot analysis. P53 protein was detected in Western blot analysis but Rb protein was not. Conclusions: This cell line exhibits many phenotypic characteristics of clinical prostate carcinoma, including expression of PSA, PSMA, PAP and AR.

AB - Background: The lack of appropriate, clinically relevant, cell-based model systems has limited prostate cancer research and the development of new therapeutic modalities. Here we report the isolation and characterization of a new adherent prostate cancer cell line, derived from the dura mater of a cancer patient. Methods: Prostate cancer tissue was harvested at autopsy from a metastatic lesion to the dura mater of a patient with hormone refractory prostate cancer. This tissue was xenografted into SCID mice and later harvested and plated on tissue culture dishes. For characterization, soft agar clonegenic assay, in vivo xenograft growth, in vitro doubling time, karyotype analysis, immunocytochemistry for cytokeratin-18, androgen receptor, and PAP (prostatic acid phosphatase) expression, RT PCR for PAP, PSMA (prostate specific membrane antigen), expression and northern and western blot analysis to determine expression of Rb and p53, were performed. Results: DuCap grows in vitro (passage 55), forms colonies in soft agar, produces tumors in SCID mice (xenograft passage 12), and is androgen sensitive. DNA content was hypertriploid. PSA was detected in mouse serum and media. Cells were AR, PAP and cytokeratin-18 positive by immunocytochemistry. PSMA and PAP were detected by RT-PCR. AR, P53, and Rb were expressed in Northern blot analysis. P53 protein was detected in Western blot analysis but Rb protein was not. Conclusions: This cell line exhibits many phenotypic characteristics of clinical prostate carcinoma, including expression of PSA, PSMA, PAP and AR.

KW - Cell line

KW - Model

KW - Prostate cancer

KW - Prostate specific antigen

KW - Xenograft

UR - http://www.scopus.com/inward/record.url?scp=0035059581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035059581&partnerID=8YFLogxK

M3 - Article

C2 - 11317521

AN - SCOPUS:0035059581

VL - 15

SP - 157

EP - 162

JO - In Vivo

JF - In Vivo

SN - 0258-851X

IS - 2

ER -